Penn Medicine Abramson Cancer Center


 

ESMO 2023 Summary: "The CLEVER Trial - Targeting Disseminated Dormant Tumor Cells With Hydroxychloroquine, Everolimus, or the Combination to Prevent Recurrent BC"

80 views
November 10, 2023
0 Comments
Login to view comments. Click here to Login
Videos